A Retrospective, Observational, Non-interventional Trial to Assess Eculizumab Treatment Effect in Patients With Atypical Hemolytic Uremic Syndrome (aHUS)

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions
Atypical Hemolytic Uremic Syndrome (aHUS)
Trial Locations (23)

Unknown

Dunwoody

Chicago

Portland

Boston

Durham

Cincinnati

Oklahoma City

Corpus Christi

Salt Lake City

Seattle

Spokane

Appleton

Graz

Innsbruck

Montreal

Caen

Le Kremlin-Bicêtre

Paris

Berlin

Heidelberg

Amsterdam

Barcelona

Bern

Sponsors
All Listed Sponsors
lead

Alexion Pharmaceuticals, Inc.

INDUSTRY